InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

- Current share price for IDX : $2.230

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$832 Initial Director's Interest Notice 20 Dec 2024 10:57AM $2.940 $2.230 fallen by 24.15%
$832 Initial Director's Interest Notice 20 Dec 2024 10:56AM $2.940 $2.230 fallen by 24.15%
$832 CAJ: Implementation of Scheme of Arrangement 20 Dec 2024 9:35AM $2.900 $2.230 fallen by 23.10%
$832 Application for quotation of securities - IDX 20 Dec 2024 9:09AM $2.900 $2.230 fallen by 23.10%
$832 Merger Update and Refinancing of Debt Facilities 20 Dec 2024 8:58AM $2.900 $2.230 fallen by 23.10%
$832 Ceasing to be a substantial holder from MS 19 Dec 2024 8:06PM $2.900 $2.230 fallen by 23.10%
$832 Change in substantial holding 19 Dec 2024 6:25PM $2.900 $2.230 fallen by 23.10%
$832 Ceasing to be a substantial holder 18 Dec 2024 8:16AM $2.940 $2.230 fallen by 24.15%
$832 Becoming a substantial holder from PPT 16 Dec 2024 5:22PM $2.980 $2.230 fallen by 25.17%
$832 Change in substantial holding 16 Dec 2024 5:00PM $2.980 $2.230 fallen by 25.17%
$832 CAJ: Scheme becomes Effective 11 Dec 2024 11:56AM $3.020 $2.230 fallen by 26.16%
$832 Proposed issue of securities - IDX 10 Dec 2024 3:18PM $2.935 $2.230 fallen by 24.02%
$832 CAJ: Court Approval of Scheme 10 Dec 2024 1:36PM $2.955 $2.230 fallen by 24.53%
$832 CAJ: ACCC provides informal merger clearance 10 Dec 2024 9:33AM $2.900 $2.230 fallen by 23.10%
$832 Merger Update 10 Dec 2024 9:30AM $2.900 $2.230 fallen by 23.10%
$832 AXX: IDX acquisit'n of CAJ unopposed, subject to divestiture 10 Dec 2024 9:22AM $2.900 $2.230 fallen by 23.10%
$832 Becoming a substantial holder from MUFG 9 Dec 2024 5:38PM $2.900 $2.230 fallen by 23.10%
$832 Becoming a substantial holder from MS 9 Dec 2024 1:16PM $2.935 $2.230 fallen by 24.02%
$832 Becoming a substantial holder 9 Dec 2024 8:17AM $2.880 $2.230 fallen by 22.57%
$832 Becoming a substantial holder 6 Dec 2024 6:00PM $2.880 $2.230 fallen by 22.57%
$832 Becoming a substantial holder 6 Dec 2024 4:18PM $2.880 $2.230 fallen by 22.57%
$832 CAJ: Merger Update 4 Dec 2024 7:27PM $3.040 $2.230 fallen by 26.64%
$832 CAJ: Scheme Meeting Results-Shareholders vote in favour 2 Dec 2024 1:01PM $2.870 $2.230 fallen by 22.30%
$832 CAJ: Merger Update 29 Nov 2024 1:24PM $2.880 $2.230 fallen by 22.57%
$832 CAJ: Notice of Second Court Hearing 26 Nov 2024 11:06AM $2.915 $2.230 fallen by 23.50%

126 - 150 of 783 results

Page 6 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.